Creatv Readies CLIA and FDA Filings for CAML-Based Cancer Blood Test
Image
Potomac, Md. – November 03, 2026 -- Creatv MicroTech is applying for CLIA approval for its LifeTracDx blood test and plans to file for FDA approvals across multiple cancer diagnostic applications, according to a profile of founder Cha-Mei Tang issued by The Inner Circle.
Microfilter built in 2010 led to discovery of cancer-associated macrophage-like cells
Creatv developed a microfilter in 2010 to capture circulating tumor cells from the blood of cancer patients. From the first patient sample, the filter also captured numerous giant cells that cancer researchers had previously ignored. Tang and Daniel L. Adams, now Chief Scientific Officer, analyzed the cells and identified them as macrophages that engulf tumor cells. The team named them cancer associated macrophage-like cells (CAMLs).